In order to minimize the risk of TSE (Transmissible Spongiform Encephalopathies) and BSE (Bovine Spongiform Encephalopathy), raw materials in the production processes are supplied only from countries without TSE/BSE status. These raw materials are processed and produced in accordance with TSE EN ISO 22442-1, 22442-2 and 22442-3 standards. Biological safety is prioritized at every stage of the production process, and the absence of TSE/BSE residue is guaranteed with internationally valid certificates.

These analyzes are carried out with the European Pharmacopoeia (EP 2.6.14 Method C) and American Pharmacopoeia (USP<85>) test methods, and the compliance of the raw materials with biological safety standards is confirmed. Thus, the safety and quality of the products are preserved at the highest level, and potential risks to human health are minimized. This meticulous control and certification process guarantees the reliability of the products and their compliance with international standards.